BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2015
View Archived Issues
Super NK cells kill tumor cells in lymph nodes
Read More
Transgenic zebra finches expressing mutant huntingtin develop vocal dysfunction
Read More
Romidepsin and Bionor's HIV vaccine Vacc-4x achieves primary endpoint in phase I/II trial
Read More
Bayer and CRISPR Therapeutics to develop potential cures for genetic diseases
Read More
Biosimilar adalimumab M-923 met primary endpoint in pharmacokinetic study
Read More
Acacia Pharma releases promising data from second pivotal phase III study of Baremsis for PONV
Read More
Mirati opens phase II trial of glesatinib, signs collaborative agreements for companion diagnostics
Read More
Alexza reports interim results from phase IIa trial of inhaled alprazolam in epilepsy
Read More
Loxo Oncology enrolls first patient in phase I trial of LOXO-101
Read More
Kiadis forms collaboration with Thalassaemia International Federation
Read More
Lilly and Halozyme to develop Enhanze subcutaneous formulations
Read More
Medidur prevents recurrence of posterior uveitis in phase III trial
Read More
Amicus Therapeutics to begin phase I/II study of ATB-200
Read More
Novoron Bioscience receives grant to evaluate new treatments for multiple sclerosis
Read More
Cantabio Pharmaceuticals and Gardedam Therapeutics complete merger
Read More
Astellas Pharma patents muscarinic M3 receptor PAMs
Read More
Tamoxifen metabolite (Z)-endoxifen active against metastatic breast cancer in trial
Read More
Novartis describes nonsense mutation suppressors
Read More
Esteve presents dual sigma1R/MOR-1 ligands
Read More
Emulate expands collaboration with Merck & Co. to use Organ-Chips in drug discovery
Read More
Merck & Co. develops sGC activators
Read More
Roche reports oxytocin agonists
Read More
Phase I trial of Panacela's cancer vaccine Mobilan underway in patients with prostate cancer
Read More
EMA confirms that MAA for AcelRx's sublingual sufentanil can use centralized procedure
Read More
SARM AUSRM-057 shows potential for colorectal cancer-associated cachexia
Read More
Cellectis seeks clearance to start first-in-human trial of UCART-19
Read More
Immuron updates on development of Clostridium difficile therapeutic IMM-529
Read More
Paclitaxel trevatide shows activity in patients with breast cancer and CNS metastases
Read More